Barijak Baricitinib 4mg Tablets

4mg Tablets, Box

4.5 (154)

850

Barijak 4mg Tablet is a JAK inhibitor used in combination with Remdesivir to treat COVID-19 in hospitalized adults. It works by blocking JAK1 and JAK2 enzymes involved in immune response, helping alleviate symptoms like fever, cough, and breathing difficulty. It requires medical supervision, with blood tests before starting treatment, and caution for patients with a history of tuberculosis, hepatitis, kidney/liver disease, or blood clots. It’s not suitable for children under 18 or during pregnancy/breastfeeding unless specifically advised by a doctor.

Description

Introduction Of Barijak Baricitinib 4mg Tablets

Barijak 4mg Tablet is used in combination with Remdesivir for the treatment of coronavirus disease (COVID-19) in hospitalized adults.

Barijak 4mg Tablet can be taken with or without food, but it is best to take them at the same time each day. Your dose will depend on your condition and what other medicines you are taking. You should use it as your doctor tells you to. Do not stop taking this medicine unless your doctor tells you to because your condition could get worse.

You may need blood tests before you are given this medicine and you should not start taking it if you have any kind of infection. Make sure you talk to your doctor before starting treatment if you have or have ever had, tuberculosis, shingles, kidney or liver disease, hepatitis B or C, or blood clots in your legs or lungs. Barijak 4mg Tablet can make you more likely to get infections or may worsen any current infections so avoid contact with people who have things you might catch (e.g., chickenpox, measles or flu). This medicine is not suitable for children under 18 years old and you should not use it if you’re pregnant or breastfeeding, unless your doctor feels the benefit is greater than the risk. Your doctor may need to examine you on a regular basis.

Uses Of Barijak 4mg Tablet

  • Treatment of Coronavirus disease (COVID-19)

Benefits Of Barijak 4mg Tablet

In Treatment of Coronavirus disease (COVID-19)

Coronavirus disease (Covid-19) is a highly infectious disease caused by a coronavirus strain named SARS-CoV2. The most common symptoms are fever, cough, loss of taste or smell, breathing difficulty, nasal congestion, and diarrhea among others. Barijak 4mg Tablet helps alleviate these symptoms but must be used only under medical supervision.

Machanism Of Action Of Barijak 4mg Tablet

Barijak 4mg Tablet is a Janus kinase (JAK) inhibitor that inhibits the activity of selective JAK1 and JAK2 enzymes, which interfere with the JAK-STAT signaling pathway (a chain of protein-cell interactions involved in processes such as immunity, cell division, cell death, and tumor formation)

Contact Us

Info Table
Strength / Dose 4 mg
Packaging Type Bottle
Packaging Size 14 Tablet
Tablets in a Bottle 14 Tablets
Usage For Covid Treatment
Vendor Info
Benefits
Reviews

Description

Introduction Of Barijak Baricitinib 4mg Tablets

Barijak 4mg Tablet is used in combination with Remdesivir for the treatment of coronavirus disease (COVID-19) in hospitalized adults.

Barijak 4mg Tablet can be taken with or without food, but it is best to take them at the same time each day. Your dose will depend on your condition and what other medicines you are taking. You should use it as your doctor tells you to. Do not stop taking this medicine unless your doctor tells you to because your condition could get worse.

You may need blood tests before you are given this medicine and you should not start taking it if you have any kind of infection. Make sure you talk to your doctor before starting treatment if you have or have ever had, tuberculosis, shingles, kidney or liver disease, hepatitis B or C, or blood clots in your legs or lungs. Barijak 4mg Tablet can make you more likely to get infections or may worsen any current infections so avoid contact with people who have things you might catch (e.g., chickenpox, measles or flu). This medicine is not suitable for children under 18 years old and you should not use it if you’re pregnant or breastfeeding, unless your doctor feels the benefit is greater than the risk. Your doctor may need to examine you on a regular basis.

Uses Of Barijak 4mg Tablet

  • Treatment of Coronavirus disease (COVID-19)

Benefits Of Barijak 4mg Tablet

In Treatment of Coronavirus disease (COVID-19)

Coronavirus disease (Covid-19) is a highly infectious disease caused by a coronavirus strain named SARS-CoV2. The most common symptoms are fever, cough, loss of taste or smell, breathing difficulty, nasal congestion, and diarrhea among others. Barijak 4mg Tablet helps alleviate these symptoms but must be used only under medical supervision.

Machanism Of Action Of Barijak 4mg Tablet

Barijak 4mg Tablet is a Janus kinase (JAK) inhibitor that inhibits the activity of selective JAK1 and JAK2 enzymes, which interfere with the JAK-STAT signaling pathway (a chain of protein-cell interactions involved in processes such as immunity, cell division, cell death, and tumor formation)

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Barijak Baricitinib 4mg Tablets”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Barijak 4mg Tablet used for?
Barijak 4mg Tablet contains Baricitinib and is used in combination with Remdesivir to treat coronavirus disease (COVID-19) in hospitalized adults, helping alleviate symptoms like fever, cough, and breathing difficulty.
It’s a Janus kinase (JAK) inhibitor that blocks the activity of JAK1 and JAK2 enzymes, interrupting the JAK-STAT signaling pathway involved in immune response and inflammation, which helps reduce the excessive immune reaction seen in severe COVID-19.
It can be taken with or without food, but it’s best taken at the same time each day. Your dose depends on your condition and other medications you’re taking, and should always follow your doctor’s specific instructions in a hospital setting.
Blood tests may be needed before starting treatment, and it should not be started if you have any active infection. Tell your doctor if you have or have had tuberculosis, shingles, kidney or liver disease, hepatitis B or C, or blood clots, since Barijak can increase infection risk.
It’s not suitable for children under 18 and should not be used during pregnancy or breastfeeding unless your doctor determines the benefit outweighs the risk. Regular medical monitoring is required throughout treatment.
No. As a hospital-administered treatment for severe COVID-19, Barijak requires close medical supervision and is only given under a doctor’s direct guidance.

Related products